PLEASE NOTE : This is a development system.
For Surrey PAD, please go to https://surreyccg.res-systems.net/PAD.
For Surrey PAD, please go to https://surreyccg.res-systems.net/PAD.
You are here : Home > PAD Profile : Ondansetron hydrochloride - Nausea and vomiting (chemotherapy induced)
PAD Profile : Ondansetron hydrochloride - Nausea and vomiting (chemotherapy induced)
Traffic Light Status
Status 1 of 3.
Status :
Blue
Important
Formulations :
- Oral solution
- Tablets
Important Information :
Oral solution reserved for use when tablets are not suitable.
On request from the specialist / Cancer Centre
Trust Alignment :
Primary Care
ASPH
RSFT
SASH
SABP
Comments :
No comments returned.
Documents :
Status 2 of 3.
Status :
Blue
Important
Formulations :
- Oro-dispersible
- Orodispersible films
Important Information :
Orodispersible preparations reserved for use when ordinary tablets are not suitable.
On request from the specialist / Cancer Centre
Trust Alignment :
Primary Care
ASPH
RSFT
SASH
SABP
Comments :
No comments returned.
Documents :
Status 3 of 3.
Guidelines
No guidelines returned.
Other Drugs
- Netupitant/palonosetron hydrochloride
- Nabilone
- Cyclizine hydrochloride
- Dexamethasone
- Domperidone
- Metoclopramide hydrochloride
- Olanzapine
- Haloperidol
- Prochlorperazine maleate
- Aprepitant
- Fosaprepitant
- Levomepromazine hydrochloride
- Granisetron
- Palonosetron hydrochloride
- Netupitant/palonosetron hydrochloride
Other Indications
Additional Documents
No additional documents returned.
Committee Recommendations
No committee recommendations returned.
Associated BNF Codes
04. Central Nervous System
04.06.00. Drugs used in nausea and vertigo